National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011
- PMID: 24043270
- PMCID: PMC10887428
- DOI: 10.1001/jamainternmed.2013.10423
National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011
Abstract
Importance: Estimating the US burden of methicillin-resistant Staphylococcus aureus (MRSA) infections is important for planning and tracking success of prevention strategies.
Objective: To describe updated national estimates and characteristics of health care- and community-associated invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in 2011.
Design, setting, and participants: Active laboratory-based case finding identified MRSA cultures in 9 US metropolitan areas from 2005 through 2011. Invasive infections (MRSA cultured from normally sterile body sites) were classified as health care-associated community-onset (HACO) infections (cultured ≤ 3 days after admission and/or prior year dialysis, hospitalization, surgery, long-term care residence, or central vascular catheter presence ≤ 2 days before culture); hospital-onset infections (cultured >3 days after admission); or community-associated infections if no other criteria were met. National estimates were adjusted using US census and US Renal Data System data.
Main outcomes and measures: National estimates of invasive HACO, hospital-onset, and community-associated MRSA infections using US census and US Renal Data System data as the denominator.
Results: An estimated 80,461 (95% CI, 69,515-93,914) invasive MRSA infections occurred nationally in 2011. Of these, 48,353 (95% CI, 40,195-58,642) were HACO infections; 14,156 (95% CI, 10,096-20,440) were hospital-onset infections; and 16,560 (95% CI, 12,806-21,811) were community-associated infections. Since 2005, adjusted national estimated incidence rates decreased among HACO infections by 27.7% and hospital-onset infections decreased by 54.2%; community-associated infections decreased by only 5.0%. Among recently hospitalized community-onset (nondialysis) infections, 64% occurred 3 months or less after discharge, and 32% of these were admitted from long-term care facilities.
Conclusions and relevance: An estimated 30,800 fewer invasive MRSA infections occurred in the United States in 2011 compared with 2005; in 2011 fewer infections occurred among patients during hospitalization than among persons in the community without recent health care exposures. Effective strategies for preventing infections outside acute care settings will have the greatest impact on further reducing invasive MRSA infections nationally.
Conflict of interest statement
Figures
Comment in
-
Methicillin-resistant Staphylococcus aureus: where is it coming from and where is it going?JAMA Intern Med. 2013 Nov 25;173(21):1978-9. doi: 10.1001/jamainternmed.2013.8277. JAMA Intern Med. 2013. PMID: 24042964 No abstract available.
-
National burden of invasive methicillin-resistant Staphylococcus aureus infection.JAMA. 2014 Apr 9;311(14):1438-9. doi: 10.1001/jama.2014.1666. JAMA. 2014. PMID: 24715075 No abstract available.
Similar articles
-
Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011.Clin Infect Dis. 2013 Nov;57(10):1393-400. doi: 10.1093/cid/cit546. Epub 2013 Aug 19. Clin Infect Dis. 2013. PMID: 23964088 Free PMC article.
-
Racial Disparities in Invasive Methicillin-resistant Staphylococcus aureus Infections, 2005-2014.Clin Infect Dis. 2018 Sep 28;67(8):1175-1181. doi: 10.1093/cid/ciy277. Clin Infect Dis. 2018. PMID: 29659728 Free PMC article.
-
Health care-associated invasive MRSA infections, 2005-2008.JAMA. 2010 Aug 11;304(6):641-8. doi: 10.1001/jama.2010.1115. JAMA. 2010. PMID: 20699455
-
Trends in invasive methicillin-resistant Staphylococcus aureus infections.Pediatrics. 2013 Oct;132(4):e817-24. doi: 10.1542/peds.2013-1112. Epub 2013 Sep 23. Pediatrics. 2013. PMID: 24062373 Review.
-
Methicillin-resistant Staphylococcus aureus infections.Top HIV Med. 2008 Dec;16(5):151-5. Top HIV Med. 2008. PMID: 19106430 Review.
Cited by
-
Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit.Infect Control Hosp Epidemiol. 2015 Jan;36(1):17-27. doi: 10.1017/ice.2014.12. Infect Control Hosp Epidemiol. 2015. PMID: 25627757 Free PMC article.
-
Epidemiology of Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections in a Large Academic Hospital: Implications for Antimicrobial Stewardship.PLoS One. 2016 Aug 24;11(8):e0161658. doi: 10.1371/journal.pone.0161658. eCollection 2016. PLoS One. 2016. PMID: 27556897 Free PMC article.
-
Pharmacodynamic Profile of GSK2140944 against Methicillin-Resistant Staphylococcus aureus in a Murine Lung Infection Model.Antimicrob Agents Chemother. 2015 Aug;59(8):4956-61. doi: 10.1128/AAC.00625-15. Epub 2015 Jun 8. Antimicrob Agents Chemother. 2015. PMID: 26055376 Free PMC article.
-
Estimating the Burden of Clinically Significant Staphylococcus aureus Infections and Predictors for Hospitalization for Skin and Soft Tissue Infections, Fulton County, Georgia, 2017.Open Forum Infect Dis. 2023 Dec 7;10(12):ofad601. doi: 10.1093/ofid/ofad601. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38107016 Free PMC article.
-
Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.Hum Vaccin Immunother. 2015;11(3):620-31. doi: 10.1080/21645515.2015.1011021. Hum Vaccin Immunother. 2015. PMID: 25715157 Free PMC article. Clinical Trial.
References
-
- Hidron AI, Edwards JR, Patel J, et al.; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare–associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29(11):996–1011. - PubMed
-
- Kallen AJ, Mu Y, Bulens S, et al.; Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Health care–associated invasive MRSA infections, 2005–2008. JAMA. 2010;304(6):641–648. - PubMed
-
- Klevens RM, Morrison MA, Nadle J, et al.; Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763–1771. - PubMed
-
- Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2005;41(suppl 4):S269–S272. - PubMed
-
- Talan DA, Krishnadasan A, Gorwitz RJ, et al.; EMERGEncy ID Net Study Group. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis. 2011;53(2):144–149. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous